AFFY (Affymax) EBITDA Margin %: 17,164.29% (As of Jun. 2014)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Affymax EBITDA Margin %?

Affymax AFFY +6.67% EBITDA Margin % is 17,164.29% as of Jun. 2014.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Affymax's EBITDA for the three months ended in Jun. 2014 was $7.21 Mil. Affymax's Revenue for the three months ended in Jun. 2014 was $0.04 Mil. Therefore, Affymax's EBITDA margin for the quarter that ended in Jun. 2014 was 17,164.29%.

Affymax  (OTCPK:AFFY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Affymax EBITDA Margin % Related Terms

Affymax EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Affymax's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Affymax EBITDA Margin % Chart

Affymax Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -65.90 -10.42 -123.72 -95.38 -1,044.19

Affymax Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,757.14 0.00 0.00 0.00 17,164.29

AFFY vs APOP, ONTX, BTHE: EBITDA Margin % Comparison

For the Biotechnology subindustry, Affymax's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affymax EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Affymax's EBITDA Margin % falls into.


Affymax EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Affymax's EBITDA Margin % for the fiscal year that ended in Dec. 2013 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=-14.295/1.369
=-1,044.19 %

Affymax's EBITDA Margin % for the quarter that ended in Jun. 2014 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2014 )/Revenue (Q: Jun. 2014 )
=7.209/0.042
=17,164.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 17,164.29% mean?
Affymax (AFFY) has a EBITDA Margin % of 17,164.29% as of Jun. 2014. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Affymax and its competitors.
Is Affymax's EBITDA Margin % too high?
Affymax's current EBITDA Margin % is 17,164.29%.
How does Affymax's EBITDA Margin % compare to APOP and ONTX?
Affymax's EBITDA Margin % of 17,164.29% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Affymax and its competitors. Affymax's current EBITDA Margin % is 17,164.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Affymax stock overvalued right now?
Affymax (AFFY) has a current EBITDA Margin % of 17,164.29%. The current EBITDA Margin % is 17,164.29%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Affymax (AFFY), the current EBITDA Margin % is 17,164.29% as of Jun. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Affymax Business Description

Address 630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020
Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.